We are live on ! Find out more
AKZOY

Akzo Nobel NV
AKZOY

Delisted

AKZOY was delisted on the 24th of August, 2007.

15 hedge funds and large institutions have $79.9M invested in Akzo Nobel NV in 2021 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 5 increasing their positions, 1 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

400% more repeat investments, than reductions

Existing positions increased: 5 | Existing positions reduced: 1

300% more first-time investments, than exits

New positions opened: 4 | Existing positions closed: 1

25% more funds holding

Funds holding: 1215 (+3)

7% less capital invested

Capital invested by funds: $86.1M → $79.9M (-$6.19M)

Holders
15
Holders Change
+3
Holders Change %
+25%
% of All Funds
0.26%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
4
Increased
5
Reduced
1
Closed
1
Calls
Puts
Net Calls
Net Calls Change

AKZOY Hedge Fund Activity: Q2 2021 in Review

15 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in Akzo Nobel NV (AKZOY) for Q2 2021, worth a combined $79.9M — down 7.2% from $86.1M a quarter earlier.

Buyers outnumbered sellers: 4 funds opened new AKZOY positions and 1 closed out — a net gain of 3 holders — while 5 added to existing stakes and 1 trimmed.

The largest buyer was Aristotle Capital Management, adding an estimated $12.6M. The largest seller was Parametric Portfolio Associates, exiting entirely with an estimated $25.9M sold.

  • 15 institutional investors held Akzo Nobel NV (AKZOY) as of Q2 2021, up from 12 in Q1 2021.
  • Funds reported $79.9M of Akzo Nobel NV stock for Q2 2021, down 7.2% quarter-over-quarter.
  • 4 funds opened new Akzo Nobel NV positions in Q2 2021 and 1 closed out, a net change of +3 holders.
  • The largest Akzo Nobel NV buyer in Q2 2021 was Aristotle Capital Management, an estimated $12.6M added.
  • The largest Akzo Nobel NV seller in Q2 2021 was Parametric Portfolio Associates, an estimated $25.9M sold.

Based on aggregated 13F filings for Q2 2021.